An Ethics Review Argued Denying Patients Medical Marijuana Violates Their Dignity and Rights | Research

The takeaway

After applying the principle of double effect to scientific evidence, an ethics review concluded there was proportionate reason to allow medical marijuana prescribing and that denying effective therapy to seriously ill patients violates their dignity.

Read this if you are interested in the ethical and human rights arguments for medical marijuana access.

IOM found medical marijuana effective for pain, nausea, wasting, and spasticity with no gateway effect

What the researchers found

This ethics review examined the medical marijuana controversy through the lens of biomedical ethics.

The factual foundation was established by the 1999 Institute of Medicine report, in which eleven independent scientists found medical marijuana effective for controlling some pain, alleviating chemotherapy-induced nausea and vomiting, treating AIDS-related wasting, and combating MS-related muscle spasms. The report also found no evidence that marijuana was a "gateway" drug or that medical use would increase illicit use.

Despite this evidence, the DEA refused to reclassify marijuana from Schedule I (no accepted medical use) to Schedule II (medical use with restrictions).

Applying the principle of double effect, a foundational framework in medical ethics for evaluating treatments that have both good and bad effects, the author concluded there was proportionate reason for allowing physicians to prescribe marijuana. The ethical argument was straightforward: seriously ill patients have a right to effective therapies, and denying access denies them dignity and respect.

Why it matters

This was one of the first formal bioethics analyses of medical marijuana policy. By framing the issue as one of patient rights and dignity rather than pharmacology alone, it introduced ethical arguments that proved influential in subsequent policy debates.

The numbers in context

Eleven IOM scientists. Four conditions with evidence: pain, chemotherapy nausea, AIDS wasting, MS spasticity. IOM found no evidence of gateway effect.

How the study worked

Ethics review applying the principle of double effect to scientific evidence from the Institute of Medicine report and other sources, examining the tension between drug policy and patient rights.

What this study cannot tell us

The ethical analysis assumed the IOM evidence was definitive, though some of the evidence was preliminary. The principle of double effect, while established in ethics, involves subjective judgments about proportionality. The review did not fully address potential harms of medical marijuana access.

How to read the evidence

An ethics review grounded in the IOM report. Provides well-reasoned ethical analysis but is ultimately an argument rather than empirical evidence.

When this study was published

Published in 2000. The ethical arguments have continued to influence policy as more states and countries have adopted medical cannabis programs.

The bigger picture

The patient rights framework articulated here influenced the medical marijuana advocacy movement and has been cited in legal challenges to cannabis scheduling. The argument that denying effective treatment violates patient dignity became a central claim in medical marijuana policy debates.

Questions still open

Does the ethical framework change as evidence accumulates? How should regulators balance individual patient rights against population-level harm concerns? Has the IOM evidence been strengthened or weakened by subsequent research?

Common questions

Is there an ethical argument for medical marijuana?

Yes. This review argued that the principle of double effect supports prescribing marijuana to seriously ill patients and that denying effective therapy violates their dignity and rights.

What did the Institute of Medicine find?

The IOM found medical marijuana effective for pain, chemotherapy nausea, AIDS wasting, and MS spasticity, and found no evidence it was a gateway drug.

Read the original research

The ethics of medical marijuana: government restrictions vs. medical necessity.

Journal of public health policy, 21(1), 40-60

View on PubMed ↗

Citation

Clark, P A. (2000). The ethics of medical marijuana: government restrictions vs. medical necessity.. Journal of public health policy, 21(1), 40-60.